Login / Signup

The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.

Dai OgataLauren E HayduIsabella C GlitzaSapna Pradyuman PatelHussein A TawbiJennifer L McQuadeAdi DiabSuhendan EkmekciogluMichael K WongMichael A DaviesRodabe N Amaria
Published in: Cancer medicine (2021)
The ORR, PFS, and OS with anti-PD-1 therapy were poor in patients with AM and MM compared to those previously reported clinical trials for nonacral CM. High serum LDH was associated with significantly shorter OS.
Keyphrases
  • clinical trial
  • squamous cell carcinoma
  • small cell lung cancer
  • randomized controlled trial
  • stem cells
  • cell therapy
  • mesenchymal stem cells
  • ulcerative colitis
  • bone marrow
  • phase iii